The Usage of Influenza Vaccine to Prevent Seasonal Influenza during Pandemic COVID-19

Yelvi Levani(1*), Ayu Lidya Paramita(2)


(1) [Scopus ID: 55200360700] FK UMSurabaya, Surabaya
(2) [GS ID: kem5FlEAAAAJ] FK UMSurabaya, Surabaya
(*) Corresponding Author

Abstract


Influenza is an acute respiratory disease caused by influenza virus. Influenza can affect million people in every year and causing morbidity. Some of cases can be severe and need hospitalized, especially in elderly people. Influenza is an airborne disease and can spread rapidly. Every seasonal flu can be different because Influenza virus do mutation. Influenza vaccine can reduce morbidity and mortality. There are two types of influenza vaccine; live attenuated influenza virus (LAIV) and inactivated influenza virus (IIV). The newest type of influenza vaccine consists four types of virus (quadrivalent), therefore it gives more protection compared to the older one. Influeza vaccine is still recommended during pandemic COVID-19 because it can prevent co-infection between Influenza and COVID-19. In addition, it can reduce the morbidity and mortality during pandemic COVID-19.


Keywords


vaccine, virus, seasonal influenza

Full Text:

PDF

References


Johnson, N.P, Mueller,J. Updating the accounts: global mortality of the 1918–1920 “Spanish” influenza pandemic. Bull Hist Med. 2002;2002(76):105–15.

Han T, Marasco WA. Structural basis of Influenza neutralization. Ann NY Acad Sci. 2011;1217:178–90.

Mosnier A, Caini S, Nauleau E. Clinical characteristics are similar across type A and B influenza virus infections. PLoS One. 2015;10(9):e0136186.

Ginsberg J et al. Detecting influenza epidemics using search engine query data. Nature. 2009;457:1012–1014.

Palese P SM. Orthomyxoviridae: The viruses and their replication. In: Knipe DM, Howley PM, editor. Fields Virology. Philadelphia, PA: Lippincott Williams & Wilkins; 2007.

CDC. How the flu virus can change: Drift and Shift. Center for Disease Control and Prevention. 2014.

Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2010;59:1–62.

Ferdinands JM, Olsho LEW, Agan AA, et al. Effectiveness of influenza vaccine against life-threatening RT-PCR-confirmed influenza illness in US children, 2010-2012. J Infect Dis. 2014;210(5):674–83.

Bridges CB, Thompson WW, Meltzer MI, Reeve GR, Talamonti WJ, Cox NJ, Lilac HA, Hall H, Klimov A FK. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial. JAMA. 2000;284:1655–63.

Kelso J. Safety of Influenza Vaccine. Curr Opin Allergy Clin Immunol. 2012;12:383–8.

CDC. Flu Vaccine and people with egg allergies [Internet]. Center for Disease Control and Prevention. 2016 [cited 2019 Jul 1]. Available from: https://www.cdc.gov/flu/protect/vaccine/egg-allergies.htm

Tapia MD, Sow SO, Boubou T, et al. Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer blind, randomised phase 4 trial. Lancet Infect Dis. 3099;16:30054–8.

Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB; Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP). Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2004;53(RR-6):1–40.

Tisa V, Barberis I, Faccio V, et al.. Quadrivalent influenza vaccine: a new opportunity to reduce the influenza burden. J Prev Med Hyg. 2016;57(1):E28–33.

Bellinghen LA, Meier G VI. The potential cost-effectiveness of quadrivalent versus trivalent influenza vaccine in elderly people and clinical risk groups in the UK: a lifetime multi-cohort model. PLoS One. 2014;9:e98437–e98437.

Kementerian Kesehatan Republik Indonesia. Berikan anak imunisasi rutin lengkap, ini rinciannya [Internet]. 2018 [cited 2019 Jul 1]. Available from: http://www.depkes.go.id/article/print/18043000011/berikan-anak-imunisasi-rutin-lengkap-ini-rinciannya.html

Suhardono M, Ugiyadi D, Nurnaeni I, Emelia I. Establishment of pandemic influenza vaccine production capacity at Bio Farma, Indonesia. Vaccine. 29AD;1A22-25.

Gupta V, Dawood FS, Muangchana C, et al. Influenza vaccination guidelines and vaccine sales in Southeast Asia: 2008 – 2011. PLoS One. 2012

World Health Organization.WHO Coronavirus (COVID-19) Disease Dashboard. WHO; 2020. Available from :https://covid19.who.int/

Worldometer. COVID-19 Coronavirus Pandemic. February 03 2021. Available from: https://www.worldometers.info/coronavirus/

World Health Organization. Coronavirus disease (COVID-19): Similarities and differences with influenza. WHO; 2020. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-covid-19-similarities-and-differences-with-influenza

Maltezou HC, Theodoridou K, Polland G. Influenza immunization and COVID-19. Vaccine; 2020 Sep 3; 38(39): 6078–6079.

Li Q., Tang B., Bragazzi N.L., Xiao Y., Wu J. Modeling the impact of mass influenza vaccination and public health interventions on COVID-19 epidemics with limited detection capacity. Math Biosci. 2020;325 108378

Richmond H, Rees N, McHale S, Rak A, Anderson J. Seasonal influenza vaccination during a pandemic. Hum Vaccin Immunother. 2020; 16(9): 2219–2221.

Researchers report 21% COVID-19 co-infection rate. Center for Infectious Disease and Policy (CIDRAP) 16 April 2020. https://www.cidrap.umn.edu/news-perspective/2020/04/researchers-report-21-covid-19-co-infection-rate

Centers for Disease Control and Prevention. Vaccination Guidance During a Pandemic [Internet] https://www.cdc.gov/vaccines/pandemic-guidance/index.html

World Health Organization. Seasonal Influenza [Internet] 2018. https://www.who.int/en/news-room/fact-sheets/detail/influenza-(seasonal)

Fink G, Orlova-Fink, Schindler T, Grisi S, Ferres APS, et al. Inactivated trivalent influenza vaccination is associated with lower mortality among patients with COVID-19 in Brazil. BMJ. 2020.

Plotkin SA. Updates on immunologic correlates of vaccine-induced protection. Vaccine 2020;38:2250–7

Netea MG, Domínguez-Andrés J, Barreiro LB, et al. Defining trained immunity and its role in health and disease. Nat Rev Immunol 2020;20:375–88


Article Metrics

Abstract view : 110 times
PDF - 24 times

DOI: https://doi.org/10.26714/magnamed.8.2.2021.93-101

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Indexed by

 

         

 

Creative Commons License

MAGNA MEDIKA by APKKM is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.